Healthy postmenopausal women receiving hrt are not at risk for early coronary events: Results from 2 large clinical trials

被引：0
|
作者：
Constantine, GD [1 ]
Pickar, JH [1 ]
Trott, EA [1 ]
机构：
[1] Wyeth Ayerst Res, St Petersburg 191011, Russia
来源：
WOMEN'S HEALTH AND MENOPAUSE: NEW STRATEGIES - IMPROVED QUALITY OF LIFE | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：231 / 238
页数：8
相关论文
共 50 条
  • [21] Teriparatide and Raloxifene Reduce the Risk of New Adjacent Vertebral Fractures in Postmenopausal Women with Osteoporosis Results from Two Randomized Controlled Trials
    Bouxsein, Mary L.
    Chen, Peiqi
    Glass, Emmett V.
    Kallmes, David F.
    Delmas, Pierre D.
    Mitlak, Bruce H.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (06): : 1329 - 1338
  • [22] Are serum estrogen concentrations associated with menopausal symptom bother among postmenopausal women? Baseline results from two MsFLASH clinical trials
    Crandall, Carolyn J.
    Larson, Joseph C.
    Ensrud, Kristine E.
    LaCroix, Andrea Z.
    Guthrie, Katherine A.
    Reed, Susan D.
    Bhasin, Shalender
    Diem, Susan
    MATURITAS, 2022, 162 : 23 - 30
  • [23] Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials
    Chen, Z
    Kooperberg, C
    Pettinger, MB
    Bassford, T
    Cauley, JA
    LaCroix, AZ
    Lewis, CE
    Kipersztok, S
    Borne, C
    Jackson, RD
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (03): : 264 - 274
  • [24] Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical Trials
    Crandall, Carolyn J.
    Larson, Joseph
    Cauley, Jane A.
    Schousboe, John T.
    LaCroix, Andrea Z.
    Robbins, John A.
    Watts, Nelson B.
    Ensrud, Kristine E.
    JBMR PLUS, 2019, 3 (12)
  • [25] Hormonal Replacement Therapy and Risk of Ulcerative Colitis and Crohn's Disease Among Postmenopausal Women: Results From a Large Prospective Cohort of US Women
    Khalili, Hamed
    Higuchi, Leslie M.
    Ananthakrishnan, Ashwin N.
    Richter, James M.
    Fuchs, Charles S.
    Chan, Andrew T.
    GASTROENTEROLOGY, 2012, 142 (05) : S88 - S89
  • [26] Lasofoxifene does not affect cognitive function in postmenopausal women: Results from two Phase 3 randomized controlled clinical trials for osteoporosis prevention
    Yaffe, K
    Petrie, CD
    Radecki, D
    Modelska, K
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S126 - S126
  • [27] Lasofoxifene does not affect cognitive function in postmenopausal women: Results from two phase 3 randomized controlled clinical trials for osteoporosis prevention
    Yaffe, K
    Petrie, C
    Radecki, D
    Modelska, K
    NEUROLOGY, 2005, 64 (06) : A145 - A145
  • [28] Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women - The EPIC-NORFOLK study
    Mallat, Ziad
    Benessiano, Joelle
    Simon, Tabassome
    Ederhy, Stephane
    Sebella-Arguelles, Carla
    Cohen, Ariel
    Huart, Virginie
    Wareham, Nicholas J.
    Luben, Robert
    Khaw, Kay-Tee
    Tedgui, Alain
    Boekholdt, S. Matthijs
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (05) : 1177 - 1183
  • [29] Is There a Higher Risk of CNS Adverse Events for PI Monotherapy Versus Triple Therapy? A Review of Results From Randomized Clinical Trials
    Powderly, William
    Hill, Andrew
    Moecklinghoff, Christiane
    HIV CLINICAL TRIALS, 2014, 15 (03): : 79 - 86
  • [30] PERIOPERATIVE CYCLOPHOSPHAMIDE IN THE MANAGEMENT OF EARLY BREAST-CANCER - RESULTS FROM 2 CLINICAL-TRIALS
    HOUGHTON, J
    RILEY, DL
    NISSENMEYER, R
    BAUM, M
    BRITISH JOURNAL OF CANCER, 1988, 58 (04) : 522 - 522
12345